MRC Technology Completes Move to Stevenage Open Innovation Campus
News Apr 20, 2016
MRC Technology, an independent life science medical research charity, has completed the move of its Centre for Therapeutics Discovery to state-of-the-art laboratory facilities at the Stevenage Bioscience Catalyst (SBC) campus. Some teams will also relocate from the central London office. The charity will still have an office in London, along with laboratories and an office in Edinburgh.
The move marks the next stage in MRC Technology’s mission to be a catalyst for life changing science, improving human health and advancing medical research. Through the open innovation network of the SBC campus, MRC Technology will have access to increased opportunities to collaborate with industry, charities, universities and health organisations to speed up life science discovery and translation processes.
Dave Tapolczay, Chief Executive Officer, MRC Technology, commented: “This is an exciting phase in MRC Technology’s development. The move provides the increased laboratory space and facilities needed to drive research and development programmes, so we can help more organisations progress innovative medical science and find solutions to some pressing health issues.”
From its inception in 2000, MRC Technology projects have led to 12 drugs on the market including Tysabri®, Actemra®, Entyvio® and Keytruda®. Research partnerships have been formed with over 40 universities and academic institutes, and alliances with 20 medical research charities. MRC Technology has generated over £630M in royalty income for research partners, enabling them to fund additional research.
Compound as Effective as FDA-Approved Drugs Against Life-Threatening InfectionsNews
Purdue University researchers have identified a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the Food and Drug Administration to treat life-threatening infections while also appearing to be less susceptible to bacterial resistance.READ MORE
Chemists Design 'Mini-ecosystems' to Test Drug FunctionNews
Scripps Research scientists have solved a major problem in chemistry and drug development by using droplet-sized 'miniecosystems' to quickly see if a molecule can function as a potential therapeutic.READ MORE
Targeting the Engine Room of the Cancer CellNews
Researchers at Columbia University Irving Medical Center (CUIMC) have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug combinations that are most likely to kill them.READ MORE
Comments | 0 ADD COMMENT
10th Annual Congress on Drug Formulation & Analytical Techniques
Sep 03 - Sep 04, 2018